🇺🇸 FDA
Patent

US 9321799

Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom

granted A61PA61P31/12A61P35/00

Quick answer

US patent 9321799 (Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom) held by Ionis Pharmaceuticals, Inc. expires Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ionis Pharmaceuticals, Inc.
Grant date
Tue Apr 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61P, A61P31/12, A61P35/00